Publications by authors named "Charles Gombe Mbalawa"

Esophageal squamous cell carcinoma (ESCC) remains the predominant histological subtype of esophageal cancer (EC) in many transitioning countries, with an enigmatic and geographically distinct etiology, and consistently elevated incidence rates in many Eastern and Southern African countries. To gain epidemiological insights into ESCC patterns across the continent, we conducted a systematic review and meta-analysis of male-to-female (M:F) sex ratios of EC age-standardised (world) incidence rates in Africa according to geography, time and age at diagnosis. Data from 197 populations in 36 countries were included in the analysis, based on data from cancer registries included in IARC's Cancer Incidence in Five Continents, Cancer in Africa and Cancer in Sub-Saharan Africa reports, alongside a systematic search of peer-reviewed literature.

View Article and Find Full Text PDF

Background: We aimed to investigate the prevalence of Lynch syndrome as one of hereditary causes of colorectal cancer (CRC) among young Congolese individuals affected by the CRC, and to define methods for diagnosis in Congo Brazzaville.

Methods: We conducted a transversal cohort study of 34 patients having a CRC with a family history for a period of eight years. They were selected among 89 CRCs of any type from the Bethesda guidelines criteria combined with pedigrees.

View Article and Find Full Text PDF

Background: Since most human papilloma virus (HPV) infections regress without any intervention, HPV is a necessary but may not be a solely sufficient cause of cervical intraepithelial neoplasia (CIN) and cervical cancer. Hence, the influence of cofactors on progression from cervical HPV infection to high-grade CIN and invasive cervical cancer has been a subject of intensive research.

Objective: We assessed the effect of socio-demographic and sexual reproductive factors on the prevalence of invasive cervical cancer and CIN diagnosed in cross-sectional cervical cancer screening projects carried out in seven sites of different sub-Saharan countries.

View Article and Find Full Text PDF

Purpose: Breast cancer is now the leading female cancer in sub-Saharan Africa, but there is relatively little information on breast cancer characteristics from this region. We studied, on a population basis, the size and stage of female breast cancer at diagnosis in Côte d'Ivoire and Republic of Congo.

Methods: Data on tumor size and stage of breast cancer at diagnosis were collected by population-based cancer registries in Abidjan (the capital of Côte d'Ivoire; 141 cases) and Brazzaville (the capital of Republic of Congo; 139 cases) from a random group of female breast cancer cases that were diagnosed in 2008-2009 using the same protocol.

View Article and Find Full Text PDF

The Brazzaville cancer registry was created in 1996 with the support of the International Agency Research against Cancer (IARC) which is located in Lyon, France. The Brazzaville cancer registry is a registry which is based on population which records new cancer cases occurring in Brazzaville by using Canreg 4.0 Software.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on comparing inflammatory breast cancer (IBC) and non-inflammatory breast cancer (NIBC) among T4 stage breast cancer patients in Brazzaville, Congo, using data collected from 2007 to 2010.
  • A total of 129 T4 breast cancer patients were analyzed, revealing no significant epidemiological differences between IBC and NIBC, but IBC was associated with larger tumor size and less frequent skin ulceration.
  • The median overall survival was significantly lower in IBC patients (9 months) compared to NIBC patients (13 months), with non-compliance to treatment intervals being a critical factor impacting chemotherapy success for both groups.
View Article and Find Full Text PDF

Justification: In many publications on cancer in Africa, the majority of patients were seen in advanced stages (III or IV) during the first consultation. So, it was important to look for factors that explain this situation.

Methods: A survey by questionnaire was made in our Medical Oncology Department of University Teaching Hospital of Brazzaville from January to October 2010.

View Article and Find Full Text PDF

The complete hydatidiform mole (CHM), a gestational trophoblastic disease, is usually caused by the development of an androgenic egg whose genome is exclusively paternal. Due to parental imprinting, only trophoblasts develop in the absence of a fetus. CHM are diploid and no abnormal karyotype is observed.

View Article and Find Full Text PDF
Article Synopsis
  • Eleven DNA samples from choriocarcinomas were analyzed using high-resolution CGH-array 244 K after confirming diagnosis and ensuring tumor DNA was free of maternal contamination.
  • The analysis revealed that de novo choriocarcinomas mostly displayed straightforward chromosomal rearrangements or normal profiles, while cell lines had complex chromosomal variations.
  • A total of 23 Minimal Critical Regions were identified, highlighting potential genes involved, with a notable presence of microRNA clusters and imprinted genes.
View Article and Find Full Text PDF

Cervical cancer is the main cancer among women in sub-Saharan Africa, India and other parts of the developing world. Evaluation of screening performance of effective, feasible and affordable early detection and management methods is a public health priority. Five screening methods, naked eye visual inspection of the cervix uteri after application of diluted acetic acid (VIA), or Lugol's iodine (VILI) or with a magnifying device (VIAM), the Pap smear and human papillomavirus testing with the high-risk probe of the Hybrid Capture-2 assay (HC2), were evaluated in 11 studies in India and Africa.

View Article and Find Full Text PDF

Objectives: The objectives of this study was to establish whether combined screening with visual inspection with acetic acid (VIA) and Lugol's iodine (VILI) improves detection of cervical intraepithelial neoplasia 2-3 (CIN 2-3) lesions and cancer beyond chance, compared with screening with VIA alone or VILI alone; and to estimate the extra number of false-positive (FP) results per additional disease case found with the combined test, and to estimate the additional costs involved.

Setting: Ten cross-sectional studies in Burkina Faso, Congo, Guinea, India, Mali and Niger, between 1999 and 2003.

Methods: Using a common protocol, health workers screened 56,147 women aged 25-65 years with VIA and VILI.

View Article and Find Full Text PDF